5-HT3 RECEPTORS AND CYTOTOXIC DRUG-INDUCED VOMITING

被引:77
作者
FOZARD, JR [1 ]
机构
[1] MERRELL DOW RES INST,F-67084 STRASBOURG,FRANCE
关键词
D O I
10.1016/0165-6147(87)90002-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:44 / 45
页数:2
相关论文
共 17 条
  • [1] BERGA P, 1986, REV FARMACOL CLIN EX, V3, P139
  • [2] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
    BRADLEY, PB
    ENGEL, G
    FENIUK, W
    FOZARD, JR
    HUMPHREY, PPA
    MIDDLEMISS, DN
    MYLECHARANE, EJ
    RICHARDSON, BP
    SAXENA, PR
    [J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576
  • [3] 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM TO PREVENT CISPLATIN-INDUCED EMESIS
    COSTALL, B
    DOMENEY, AM
    NAYLOR, RJ
    TATTERSALL, FD
    [J]. NEUROPHARMACOLOGY, 1986, 25 (08) : 959 - 961
  • [4] FLORCZYK AP, 1982, CANCER TREAT REP, V66, P187
  • [5] Fozard J R, 1982, Adv Neurol, V33, P295
  • [7] BLOCKADE OF NEURONAL TRYPTAMINE RECEPTORS BY METOCLOPRAMIDE
    FOZARD, JR
    MOBAROKALI, ATM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 49 (01) : 109 - 112
  • [8] FOZARD JR, 1986, 3RD P SCI RSC MED CH, P37
  • [9] METOCLOPRAMIDE - A REVIEW OF ANTI-EMETIC TRIALS
    GRALLA, RJ
    [J]. DRUGS, 1983, 25 : 63 - 73
  • [10] METOCLOPRAMIDE - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE
    HARRINGTON, RA
    HAMILTON, CW
    BROGDEN, RN
    LINKEWICH, JA
    ROMANKIEWICZ, JA
    HEEL, RC
    [J]. DRUGS, 1983, 25 (05) : 451 - 494